GEIZX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GEIZX Analyst Rating

Strong Buy

297 Buy

53 Hold

5 Sell

Based on the consensus analyst ratings on 355 stocks held in GEIZX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GEIZX Analyst Price Target

Average Price Target

$16.10

Based on 355 Wall Street analysts offering 12 month price targets to Growth Equity Index Fund - Investor Class holdings in the last 3 months. The average price target is $16.10 with a high forecast of $19.29 and a low forecast of $12.22. The average price target represents a 9.19% change from the last price of $14.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","20":"$20","13.25":"$13.25","15.5":"$15.5","17.75":"$17.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.285,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$19.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.095,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.22</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,13.25,15.5,17.75,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,17.268076923076926,17.436153846153847,17.60423076923077,17.77230769230769,17.940384615384616,18.10846153846154,18.27653846153846,18.444615384615386,18.61269230769231,18.78076923076923,18.948846153846155,19.116923076923076,{"y":19.285,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,17.02269230769231,16.945384615384615,16.868076923076924,16.790769230769232,16.713461538461537,16.636153846153846,16.558846153846154,16.481538461538463,16.404230769230768,16.326923076923077,16.249615384615385,16.17230769230769,{"y":16.095,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,16.72492307692308,16.349846153846155,15.974769230769231,15.599692307692308,15.224615384615385,14.849538461538462,14.47446153846154,14.099384615384615,13.724307692307693,13.349230769230768,12.974153846153847,12.599076923076924,{"y":12.224,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.54,"date":1719792000000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.88,"date":1722470400000,"info":"<div>Price: <b>$15<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.01,"date":1725321600000,"info":"<div>Price: <b>$15<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.67,"date":1727740800000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.96,"date":1730419200000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.02,"date":1733097600000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.35,"date":1735776000000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.53,"date":1738540800000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.71,"date":1740960000000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.88,"date":1743465600000,"info":"<div>Price: <b>$15<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.19,"date":1746057600000,"info":"<div>Price: <b>$15<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.43,"date":1748822400000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.1,"date":1751328000000,"info":"<div>Price: <b>$17<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$19.29

Average Price Target$16.10

Lowest Price Target$12.22

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GEIZX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RARE

Ultragenyx Pharmaceutical, Inc.

14 Buy

1 Hold

0 Sell

Strong Buy

$82.67

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VKTX

Viking Therapeutics

13 Buy

0 Hold

0 Sell

Strong Buy

$97.64

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SRPT

Sarepta Therapeutics Inc.

9 Buy

15 Hold

2 Sell

Moderate Buy

$38.17

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NFE

New Fortress Energy

2 Buy

2 Hold

0 Sell

Moderate Buy

$8.83

xxxxxxxxxxxxxxxxxxxxxxxxxxx

APLS

Apellis Pharmaceuticals

10 Buy

7 Hold

0 Sell

Moderate Buy

$37.25

GEIZX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PLTR

Palantir Technologies Inc.

3 Buy

10 Hold

3 Sell

Hold

$104.85

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RBLX

Roblox Corp.

14 Buy

4 Hold

2 Sell

Moderate Buy

$90.40

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Ubiquiti Networks Inc

1 Buy

0 Hold

1 Sell

Hold

$343.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Unity Software, Inc.

7 Buy

6 Hold

1 Sell

Moderate Buy

$27.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

COIN

Coinbase Global, Inc.

13 Buy

11 Hold

1 Sell

Moderate Buy

$326.40

GEIZX Mutual Fund FAQ

What is GEIZX’s average 12-month price target, according to analysts?

Based on analyst ratings, Growth Equity Index Fund - Investor Class’s 12-month average price target is 16.10.

What is GEIZX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GEIZX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GEIZX a Buy, Sell or Hold?

Growth Equity Index Fund - Investor Class has a consensus rating of Strong Buy which is based on 297 buy ratings, 53 hold ratings and 5 sell ratings.

What is Growth Equity Index Fund - Investor Class’s price target?

The average price target for Growth Equity Index Fund - Investor Class is 16.10. This is based on 355 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $19.29 ,the lowest forecast is $12.22. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Growth Equity Index Fund - Investor Class?

Growth Equity Index Fund - Investor Class’s analyst rating consensus is a Strong Buy. This is based on the ratings of 355 Wall Streets Analysts.

How can I buy shares of GEIZX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing